PT87522A - Verfahren zum nachweis der antiaggregatorischen wirkung von vasoaktiven stoffen speziell von phosphodiesterase- und/oder cyclooxygenase-hemmern - Google Patents

Verfahren zum nachweis der antiaggregatorischen wirkung von vasoaktiven stoffen speziell von phosphodiesterase- und/oder cyclooxygenase-hemmern

Info

Publication number
PT87522A
PT87522A PT87522A PT8752288A PT87522A PT 87522 A PT87522 A PT 87522A PT 87522 A PT87522 A PT 87522A PT 8752288 A PT8752288 A PT 8752288A PT 87522 A PT87522 A PT 87522A
Authority
PT
Portugal
Prior art keywords
von
added
cyclooxygenase
phosphodiesterase
vasoaktiven
Prior art date
Application number
PT87522A
Other languages
English (en)
Other versions
PT87522B (pt
Inventor
Klans Ulrich Weithmann
Dirk Seiffge
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PT87522A publication Critical patent/PT87522A/pt
Publication of PT87522B publication Critical patent/PT87522B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT87522A 1987-05-22 1988-05-19 Processo para a determinacao do efeito anti-agregante de compostos vasoactivados, em especial de inibidores da fosfodiesterase e/ou da ciclooxigenase PT87522B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873717337 DE3717337A1 (de) 1987-05-22 1987-05-22 Verfahren zum nachweis der antiaggregatorischen wirkung von vasoaktiven stoffen, speziell von phosphodiesterase- und/oder cyclooxygenase-hemmern

Publications (2)

Publication Number Publication Date
PT87522A true PT87522A (pt) 1989-05-31
PT87522B PT87522B (pt) 1992-09-30

Family

ID=6328208

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87522A PT87522B (pt) 1987-05-22 1988-05-19 Processo para a determinacao do efeito anti-agregante de compostos vasoactivados, em especial de inibidores da fosfodiesterase e/ou da ciclooxigenase

Country Status (9)

Country Link
US (1) US4983514A (pt)
EP (1) EP0291873B1 (pt)
JP (1) JPS63300965A (pt)
AT (1) ATE86671T1 (pt)
DE (2) DE3717337A1 (pt)
DK (1) DK165712C (pt)
ES (1) ES2054731T3 (pt)
IE (1) IE62525B1 (pt)
PT (1) PT87522B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4038898A1 (de) * 1990-12-06 1992-06-11 Michaelis Peter Dr Verfahren zum vergleich der wirkung und/oder der bioverfuegbarkeit therapeutisch wirksamer stoffgemische
JPH06510020A (ja) * 1991-03-29 1994-11-10 ユニバーシティ・オブ・フロリダ 混成リン酸エステル誘導体を経た標的への薬剤供給
ATE208493T1 (de) * 1994-06-30 2001-11-15 Dade Behring Inc Bioaktive poröse trennteile
US5622867A (en) * 1994-10-19 1997-04-22 Lifecell Corporation Prolonged preservation of blood platelets
US5919614A (en) * 1994-10-19 1999-07-06 Lifecell Corporation Composition comprising three platelet lesion inhibitors for platelet storage
US6221669B1 (en) 1994-10-19 2001-04-24 Lifecell Corporation Prolonged preservation of blood platelets
US5958716A (en) * 1996-06-06 1999-09-28 Dade Behring Inc. Blood factor assay
US20020018989A1 (en) * 1996-11-07 2002-02-14 Albert Beaufour Method of identifying pharmaceuticals from plant extracts
WO1998027213A1 (en) * 1996-12-18 1998-06-25 Medical Research Council Lysophosphatidic acid acyltransferase gene and its use
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
US6593369B2 (en) * 1997-10-20 2003-07-15 Vivus, Inc. Methods, compositions, and kits for enhancing female sexual desire and responsiveness
RU2150700C1 (ru) * 1999-04-27 2000-06-10 Волчек Игорь Владимирович Способ скрининга лекарственных препаратов
RU2235318C2 (ru) * 2002-01-31 2004-08-27 Музыка Владислав Иванович Способ оценки индивидуальной чувствительности организма к лекарственным препаратам
RU2222011C1 (ru) * 2002-04-24 2004-01-20 Государственное образовательное учреждение высшего профессионального образования Санкт-Петербургская государственная медицинская академия им. И.И.Мечникова Способ индивидуального подбора лекарственных препаратов для лечения больных этиологически различными острыми и хроническими вирусными гепатитами
RU2221243C1 (ru) * 2002-04-29 2004-01-10 ГОУВПО Санкт-Петербургская государственная медицинская академия им. И.И.Мечникова Способ подбора лекарственных препаратов для лечения больных хроническим вирусным гепатитом c
RU2235319C1 (ru) * 2002-12-17 2004-08-27 Савина Лидия Васильевна Способ экспресс-прогнозирования метаболической реабилитации с помощью вольфии бескорневой
US20070243632A1 (en) * 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
ES2668551T3 (es) 2005-09-26 2018-05-18 Lifecell Corporation Composición seca de plaquetas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051236A (en) * 1973-02-15 1977-09-27 E. R. Squibb & Sons, Inc. Inhibition of blood platelet aggregation
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
DE3515874A1 (de) * 1984-07-21 1986-01-23 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus pyrimido-pyrimidinen und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
EP0169465B1 (de) * 1984-07-21 1990-02-28 Hoechst Aktiengesellschaft Kombinationspräparat aus Pyrimido-pyrimidinen und O-Acetylsalicylsäure bzw. deren pharmakologisch verträglichen Salzen und dessen Verwendung
DE3524051A1 (de) * 1985-07-05 1987-01-15 Hoechst Ag Kombinationspraeparate aus hemmstoffen der thrombozytenaggregation und deren verwendung
DE3526362A1 (de) * 1985-07-19 1987-01-22 Schering Ag Prostacycline, ihre analoga oder prostaglandine und thromboxanantagonisten zur behandlung von thrombotischen und thromboembolischen krankheitsbildern

Also Published As

Publication number Publication date
EP0291873A2 (de) 1988-11-23
PT87522B (pt) 1992-09-30
DK277988D0 (da) 1988-05-20
EP0291873B1 (de) 1993-03-10
ATE86671T1 (de) 1993-03-15
JPS63300965A (ja) 1988-12-08
IE62525B1 (en) 1995-02-08
IE881523L (en) 1988-11-22
DK165712B (da) 1993-01-04
DE3717337A1 (de) 1988-12-15
DE3878980D1 (de) 1993-04-15
DK165712C (da) 1993-06-07
EP0291873A3 (en) 1989-10-11
US4983514A (en) 1991-01-08
ES2054731T3 (es) 1994-08-16
DK277988A (da) 1988-11-23

Similar Documents

Publication Publication Date Title
ATE86671T1 (de) Verfahren zum nachweis der antiaggregatorischen wirkung von vasoaktiven stoffen, speziell von phosphodiesterase- und/oder cyclooxygenasehemmern.
SE8402551L (sv) Cinnamoylmoranolin-derivat
SE7803045L (sv) Givare for metning av syrekoncentrationen i gaser
NO783025L (no) Fremgangsmaate for fremstilling av (d-alfa-amino-(p-hydroksyfenyl)-acetamido)-gruppeholdige penicillansyre og cefalosporansyrederivater
DK153039C (da) Fremgangsmaade til fremstilling af et til anvendelse som eller i dyrefoder beregnet produkt af fuldblod eller blodderivater indeholdende roede blodlegemer eller animalsk vaev indeholdende saadant blod.
SE7705370L (sv) 12-azaprostanoinsyror
CA952799A (en) Method of determining hemoglobin in blood
AT306253B (de) Verfahren zur Herstellung von neuen Adenosin-5'-carbonsäurederivaten
SE8302552L (sv) ( (1-bensyl-1h-indazol-3-yl)oxi) ettiksyrasalt med lysin
IT1086096B (it) Procedimento per la concentrazione di soluzioni acquose di acido solforico
CH387060A (de) Verfahren zur Herstellung von neuen Di-(ortho-phosphorsäure)-monoestern
AT361124B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen zur topischen verabreichung an das auge
PT67537B (fr) Acides amino-spiro /oxa (ou tia)cicloalcane-penam/-carboxyliques
IT1201210B (it) Metodo rapido di prova per determinare la sedimentazione del sangue venoso
CH387053A (de) Verfahren zur Herstellung von Thioestern von Phosphorsäure-Derivaten
FR2347686A1 (fr) Tube a prelevement pour le dosage de la glycemie
NL7415518A (nl) Gesubstitueerde (alpha)-aminooxyhydroxaamzuur deriva- ten en werkwijzen voor hun bereiding en toepas- sing.
JPS53125897A (en) Measurment of concentration of alkali or acid
JPS531085A (en) Measuring method of sulfuric acid polysaccharide concentration in blood
IT1099606B (it) Diagnostico rapido per la determinazione dell'acido urico in liquidi corporei
SE7903631L (sv) Forfarande for bestemning av kalciumnivan i blod
JPS53121718A (en) S*ssdecamethylenee1*100mercaptan derivative useful as blood lipid concentration normalizing agent
AT303964B (de) Verfahren zur Herstellung von 6-Amino-penicillansäure-Derivaten
CH484191A (de) Verfahren zur Herstellung von N-Acylderivaten der 6-Amino-penicillansäure
DK113276A (da) Diagnostisk middel til kontrol af koaguleringsevnen for blod

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920311

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19960930